RISS STAGE I PLASMA CELL MYELOMA
Clinical trials for RISS STAGE I PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RISS STAGE I PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for RISS STAGE I PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a fourth drug boost myeloma treatment? large trial recruits 1,450 patients
Disease control Recruiting nowThis study compares a four-drug combination (daratumumab, bortezomib, lenalidomide, and dexamethasone) against a three-drug combination (daratumumab, lenalidomide, and dexamethasone) in people newly diagnosed with multiple myeloma who are not eligible for early stem cell transpla…
Matched conditions: RISS STAGE I PLASMA CELL MYELOMA
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jun 08, 2026 13:17 UTC
-
2000 volunteers help create a gold standard for cancer blood tests
Knowledge-focused Recruiting nowThis study collects blood and tissue samples from 2000 people—some with cancer and some without—to create a blinded reference set. Researchers will use these samples to evaluate how well new blood tests can detect many types of cancer early. The goal is to improve the accuracy of…
Matched conditions: RISS STAGE I PLASMA CELL MYELOMA
Sponsor: Alliance for Clinical Trials in Oncology • Aim: Knowledge-focused
Last updated Jun 16, 2026 22:34 UTC